FEED

TYLER, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue" or the "Company"), a commercial-stage medical device company, today announced a new exclusive distribution agreement with Peak Medical, a complete medical equipment solutions company, to expand commercial distribution of ENvue’s UroShield® device across the United Kingdom and Republic of Ireland. The agreement includes minimum purchase commitments of approximately $2.6 million over its initial term through December 31, 2029, creating a meaningful opportunity to expand market access and drive revenue growth for UroShield. "UroShield helps patients avoid painful, recurring catheter-associated infections, an

10-Q - ENvue Medical, Inc. (0001326706) (Filer)

NT 10-Q - ENvue Medical, Inc. (0001326706) (Filer)

TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that it has entered into a securities purchase agreement ("ELOC") with an institutional investor providing the Company with an equity facility for up to $50 million in capital (the "Facility"), subject to the terms and conditions of the agreement, including the receipt of stockholder approval. The facility strengthens ENvue’s financial flexibility and supports the Company’s plans to advance its next-generation technology platform and evaluate selective strategic acquisition and business development opportunities. "Our

8-K - ENvue Medical, Inc. (0001326706) (Filer)

S-3 - ENvue Medical, Inc. (0001326706) (Filer)

TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue" or the "Company"), a commercial-stage medical device company, today announced it has completed the transition of its NanoVibronix manufacturing operations from Israel to the United States, and consolidated its research and development operations in Tel Aviv, Israel, supporting the Company’s broader initiative to reduce operating expenses and improve its cost structure. "Completing the transition of our NanoVibronix product line manufacturing to the United States marks the achievement of a major strategic operational initiative for the Company," said Doron Besser, MD, CEO of ENvue Medical. "By consol

DEF 14A - ENvue Medical, Inc. (0001326706) (Filer)

TYLER, Texas, July 23, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced the deployment of an additional ENvue™ Navigation Platform at a major academic medical center in the Dallas-Fort Worth Metroplex. The existing medical center customer serves a high volume of hospitalized patients annually and has expanded ENvue deployment as clinicians continue to adopt the platform across care settings. "The most rigorous clinical environments do not expand their use of a technology unless it's working," said Marc Waldman, Vice Preside

Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12 Years as Director General of Sheba Medical Center Zvi Joseph and Lior Buchman Join Board, Bringing Amdocs AI Governance Leadership and $320 Million in Executed Financings and M&A, Respectively TYLER, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that Zeev Rotstein, M.D., a current board member and internationally recognized health system leader, has been named Chairman of the Board, succeeding David Johnson

PRE 14A - ENvue Medical, Inc. (0001326706) (Filer)

8-K - ENvue Medical, Inc. (0001326706) (Filer)

8-K - ENvue Medical, Inc. (0001326706) (Filer)

4 - ENvue Medical, Inc. (0001326706) (Issuer)

AI-based platform, ‘Ask Oscar™', to accelerate adoption of ENvue's Navigation Platform and enable clinicians to train independently and reduce implementation barriers  See Ask Oscar in action: https://envuemed.com/ask-oscar/#video TYLER, Texas, June 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today introduced ‘Ask Oscar™', a new AI-powered training platform designed to address one of the biggest barriers to adoption of medical technology: training. The platform marks the Company's transformation from a medical device maker int

TYLER, Texas, June 05, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical," or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that a major U.S. academic health network has expanded its use of the ENvue™ Navigation Platform into its American Burn Association-verified burn intensive care unit, marking the second deployment within the same health system and expanding access to ENvue's technology for a particularly vulnerable patient population. "We believe that this health network's decision to bring the ENvue Navigation Platform into their burn ICU speaks directly to the clinica

Independent, Peer-Reviewed Study Demonstrated Significant Improvement in Patient Outcomes, Reduction in Over 350 Nursing Hours in Year One, and 20% Decrease in Repeat Imaging Validates Value of Integrating ENvue Navigation Platform as Standard of Care in U.S. Hospitals, Saving Costs on Nursing Hours, Imaging, and Patient Complications Findings Published in Official Journal of the American Association of Critical Care Nurses TYLER, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that an independent, peer-reviewed study has

EFFECT - ENvue Medical, Inc. (0001326706) (Filer)

424B3 - ENvue Medical, Inc. (0001326706) (Filer)

TYLER, Texas, May 19, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced that the Company will participate as an exhibitor at the American Association of Critical Care Nurses National Teaching Institute & Critical Care Exposition ("AACN NTI") 2026, taking place May 21–22, 2026. Recognized as the largest critical care nursing conference in the United States, AACN NTI brings together thousands of frontline nurses, nurse leaders, educators and healthcare professionals from leading hospitals and healthcare systems nationwide. "Cr

S-3 - ENvue Medical, Inc. (0001326706) (Filer)

10-Q - ENvue Medical, Inc. (0001326706) (Filer)

NT 10-Q - ENvue Medical, Inc. (0001326706) (Filer)

144 - ENvue Medical, Inc. (0001326706) (Subject)

TYLER, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) ("ENvue," "ENvue Medical" or the "Company"), a commercial-stage medical device company focused on real-time guided bedside feeding tube placement, today announced a three-year contract renewal by a leading integrated nonprofit health system operating 12 hospitals across Virginia and North Carolina. The ENvue™ Navigation Platform has been adopted as the standardized protocol for bedside enteral feeding tube placement across all hospitals within the network. Standardization at the health system level represents significant commercial validation in medical device adoption. Unlike contracted access — which makes